POULMMUNE™ SALMONELLA BCD

Salmonella Prevention in the Poultry Industry

For decades, Salmonellosis has posed a significant threat to public health across all continents worldwide. The ubiquitous nature of Salmonella allows these microorganism to survive and adapt to various environments, including animal, human, and non-animal hosts. As such, Salmonella control has historically been a major challenge for producers and regulators across the farm-to-fork food supply chain.¹

Salmonella prevention programs in poultry are designed to 1) prevent hatching eggs, day-old chicks, and pullets from becoming infected in primary production; and 2) prevent feed, water, poultry facilities, rodents and fomites from becoming the source of infection for those non-infected poultry flocks.²

Considering the above, the poultry industry needs to invest in integrated risk management programs, including vaccines technologies capable to 1) prevent the intestinal colonization, 2) minimize systemic dissemination and invasion of reproductive tract, and 3) reduce faecal shedding and egg shell contamination.² 

Use POULMMUNE™ SALMONELLA BCD in your integrated risk management program to provide broader coverage against Salmonellosis.

Product Description

Withdrawal

Zero days. 

Additional Features

• Broad umbrella of protection reducing colonization and faecal excretion by serovars belonging to multiple serogroups: S. Typhimurium (serogroup B), S. Kentucky (serogroup C), S. Enteritidis, S. Gallinarum (both belonging to serogroup D).
• Strong systemic humoral immunity.
• No shedding of the vaccine strains in the environment.
• No persistence of the vaccine strains in the flock.
• No traces of the vaccine strains in table eggs.
• Progeny protected during the first days of age.

Dosage

The vaccine dose (0.5 mL/bird) should be administered subcutaneously in the lower part of the neck or intramuscularly into the chest muscles.

Administration

Before use, the vaccine should be shaken well to ensure proper mixing. Sterile injection equipment should be used to avoid contamination.

• Subcutaneous injection: apply in the lower part of the neck. The needle should be inserted just under the skin in a direction away from the head and in a straight line with the neck.
• Intramuscular injection: when applied in the breast muscles the needle must be inserted with a 45° angle to avoid intraperitoneal injection.

The vaccine may occasionally separate into two layers on storage. This in no way affects its potency, but the vaccine should be shaken vigorously before and during use to ensure good emulsification. Do not use POULMMUNE™ SALMONELLA BCD if you notice critical irreversible separation of the emulsion.

Storage Precautions

• Store and transport refrigerated (+2°C to +8°C).
• Do not freeze.
• Store in a dry place protected from direct sunlight.
• Do not use this product after the expiry date.
• Shelf life after first opening the bottle: 3 hours.

Presentation

POULMMUNE™ SALMONELLA BCD is packed and presented in 500 mL (1000 doses) polyethylene terephthalate (PET) bottles.

References

1. Teklemariam, A. et. al. (2023). Human Salmonellosis: A Continuous Global Threat in the Farm-to-Fork Food Safety Continuum. Foods 2023, 12, 1756. https://doi.org/10.3390/foods12091756.

2. Ulrich Methner (2010). Vaccination of poultry against Salmonella: what is the ideal vaccine (strain)?. Friedrich-Loeffler-Institute, Federal Institute for Animal Health, Jena Branch, Naumburger Str.96a, D-07743 Jena, Germany.

Ready to Discuss Salmonella Prevention?

Fill out the form below to connect with Kemin's vaccine experts

The content on this site is intended for informational purposes only and is not intended to be a substitute for professional veterinary advice. Although the information on this site is accessible worldwide, not all products or services are available to all persons or in all geographic locations or jurisdictions. Certain statements, product labeling and claims may differ by geography or as required by local governmental regulations.